Pressmeddelande -
Press invitation: "ATMP world tour" 2021
The very first ”ATMP world tour” is aimed at highlighting ’world leading’ activities within Advanced Therapy Medicinal Products (ATMPs). The speakers come from all over the world and will share their extensive knowledge in varied aspects of the ATMP pipeline on a global stage towards better treatments solutions for patients worldwide. Topics include patient driven development, manufacture, commercialisation, education, hospital exemption, national networks.
The event is virtually, April 26-30, 2021. There will be 20 speakers over the week, 4 per day. It is not anticipated that registrants will attend all presentations due to the diversity of topics and level of speakers.
Program:
MONDAY APRIL 26TH, 1PM-5PM CET
13:00: Innovation driven National networking” ATMP Sweden”
Speaker: Frida Lundmark, LIF, Stockholm, Sweden.
Host: Mark Lowdell, CAMP IAB/Royal Free Hospital, London, UK.
14:00: Patient involvement and advocacy for product development.
Speaker: Sven Kili, Antion Biosciences, UK.Host: Christoph Varenhorst, Pfizer, Stockholm, Sweden.
15:00: Pluripotent stem cells – ’the non-existent’ business model
Speaker: Mattias Hansson, Novo Nordisk, Lund, Sweden. Host: Petter Björquist, VERIGRAFT, Gothenburg, Sweden.
16:00 Reflections on the US ATMP ecosystem
Speaker: Stephen Majors, ARM, USA. Host: Petter Björquist, VERIGRAFT, Gothenburg, Sweden.
TUESDAY APRIL 27TH, 8AM-12PM CET
8:00 Clinical trials and reimbursement
Speaker: John Rasko, The University of Sydney, Australia. Host: Stephan Mielke, Karolinska University Hospital, Stockholm, Sweden.
9:00 Clinical iPSC commercialisation and industrial manufacture
Speaker: Ross Macdonald, Cynata, Australia. Host: Kristina Runeberg, Takara Bio Europe, Gothenburg, Sweden.
10:00 Stimulating industry and international partnering
Speaker: So Ra Park, SCRM, South Korea. Host: Dag Larsson, LIF, Stockholm, Sweden.
11:00: Education programs and competence development
Speaker: Quasim Rafiq, University College London, UK. Host: Paul Kingham, Umeå University, Sweden.
WEDNESDAY APRIL 28TH, 2PM-6PM CET
14:00 Research translation and clinical trials support
Speaker: Roke Oruezabal, CAMP IAB/AND & TAT, Seville, Spain. Host: Lilian Walther Jallow,BOOST Pharma ApS, Stockholm, Sweden.
15:00: CAR T Commercialization – Challenges on the way
Speaker: Irene Aldecoa Bilbao, Celgene/BMS, Switzerland. Host: Åse Rosenqvist, Janssen-Cilag AB/CAMP board member, Stockholm, Sweden.
16:00: Process development and commercialisation support
Speaker: Michael May, CAMP IAB/CCRM, Toronto, Canada. Host: Jim Lund, RISE, Karlskoga, Sweden.
17:00: Advocacy driven innovation
Speaker: Robert Klein, Americans For Cures, California, USA. Host: Bettina Ryll, Uppsala, Sweden.
THURSDAY APRIL 29TH, 8AM-12PM CET
8:00: Academic v commercial models for hospital ATMP manufacture facilities
Speaker: Dominic Wall, Cell Therapies Pty Ltd, Melbourne, Australia. Host: Pontus Blomberg, KCC/Vecura, Stockholm, Sweden.
9:00: Hospital exemption v commercialisation
Speaker: Graziella Pellegrini, University of Modena and Reggio Emilia, Italy. Host: Anders Lindahl, University of Gothenburg, Sweden.
10:00: Commercialisation models then and now
Speaker: Jaap Twisk, UniQure, Amsterdam, Netherlands. Host: Karin Hoogendoorn, CAMP International Advisor, Netherlands.
11:00 National facilitator network
Speaker: Jacqueline Barry, Cell and Gene Therapy Catapult, London, UK. Host: Johan Hyllner, AstraZeneca/CAMP board member, Gothenburg, Sweden.
FRIDAY APRIL 30TH, 8AM-12PM CET
8:00: FIRM, National facilitator functions
Speaker: Masayuki (Max) Nomura, FIRM, Japan. Host: Kristina Kannisto, KCC, Stockholm, Sweden.
9:00: International collaborative networks for negotiations and HTA
Speaker: Iselin Dahlen Syversen, Norway. Host: Sofie Alverlind, SKR, Stockholm, Sweden.
10:00: Manufacturing Gene Therapies for pre-clinical and clinical studies
Speaker: Seppo Yla-Herttuala, University of Kuopio, Finland. Host: Karin Agerman, CombiGene, Lund, Sweden.
11:00: Partnerships and collaboration for ATMP manufacture
Speaker: Bill Shingleton, Cytiva, UK. Host: Margareta Tennander – Cytiva/CAMP board member, Uppsala, Sweden.
Register here:
https://www.eventbrite.com/e/atmp-world-tour-2021-tickets-136934668279
More information about ATMP Sweden:
Ämnen
Lif är branschorganisationen för de forskande läkemedelsföretagen i Sverige. Vi arbetar för en högkvalitativ vård och tillgången till nya behandlingar genom att stärka den svenska Life Science-sektorn i samverkan med vårdens aktörer, politiker, tjänstemän och patientföreträdare. Lif har närmare 100 företag som medlemmar.
